303 related articles for article (PubMed ID: 15247411)
1. Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo.
Ikeda Y; Imai Y; Kumagai H; Nosaka T; Morikawa Y; Hisaoka T; Manabe I; Maemura K; Nakaoka T; Imamura T; Miyazono K; Komuro I; Nagai R; Kitamura T
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10732-7. PubMed ID: 15247411
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta.
Topouzis S; Majesky MW
Dev Biol; 1996 Sep; 178(2):430-45. PubMed ID: 8830742
[TBL] [Abstract][Full Text] [Related]
3. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration.
Pyagay P; Heroult M; Wang Q; Lehnert W; Belden J; Liaw L; Friesel RE; Lindner V
Circ Res; 2005 Feb; 96(2):261-8. PubMed ID: 15618538
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A
Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells.
Ninomiya K; Takahashi A; Fujioka Y; Ishikawa Y; Yokoyama M
Hypertens Res; 2006 Apr; 29(4):269-76. PubMed ID: 16778334
[TBL] [Abstract][Full Text] [Related]
6. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
[TBL] [Abstract][Full Text] [Related]
7. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of nestin in vascular smooth muscle cells in vivo and in vitro.
Oikawa H; Hayashi K; Maesawa C; Masuda T; Sobue K
Exp Cell Res; 2010 Apr; 316(6):940-50. PubMed ID: 19896481
[TBL] [Abstract][Full Text] [Related]
9. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation.
LeClair RJ; Durmus T; Wang Q; Pyagay P; Terzic A; Lindner V
Circ Res; 2007 Mar; 100(6):826-33. PubMed ID: 17322174
[TBL] [Abstract][Full Text] [Related]
10. Hic-5, an adaptor protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo.
Kim-Kaneyama JR; Wachi N; Sata M; Enomoto S; Fukabori K; Koh K; Shibanuma M; Nose K
Biochem Biophys Res Commun; 2008 Nov; 376(4):682-7. PubMed ID: 18812162
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
12. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
13. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells.
Xu Q; Li S; Zhao Y; Maures TJ; Yin P; Duan C
Circ Res; 2004 Mar; 94(5):E46-54. PubMed ID: 15001525
[TBL] [Abstract][Full Text] [Related]
14. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors.
Wu X; Ma J; Han JD; Wang N; Chen YG
Microvasc Res; 2006 Jan; 71(1):12-9. PubMed ID: 16405919
[TBL] [Abstract][Full Text] [Related]
15. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
Santander C; Brandan E
Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells.
Kurpinski K; Lam H; Chu J; Wang A; Kim A; Tsay E; Agrawal S; Schaffer DV; Li S
Stem Cells; 2010 Apr; 28(4):734-42. PubMed ID: 20146266
[TBL] [Abstract][Full Text] [Related]
20. The effect of TGF-beta receptor binding peptides on smooth muscle cells.
Michon IN; Penning LC; Molenaar TJ; van Berkel TJ; Biessen EA; Kuiper J
Biochem Biophys Res Commun; 2002 May; 293(4):1279-86. PubMed ID: 12054515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
